Third-line chemotherapy in advanced gastric cancer: A systematic review and meta-analysis

BACKGOUND: Little information regarding to the survival advantage of third-line chemotherapy in advanced gastric cancer patients is available. The current study is designed to systematically review and perform meta-analysis on the effect of third-line chemotherapy on progressive or recurrent gastric...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yu, Zhu, Xu-Qing, Ren, Xiao-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478304/
https://www.ncbi.nlm.nih.gov/pubmed/28614219
http://dx.doi.org/10.1097/MD.0000000000006884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478304/
https://www.ncbi.nlm.nih.gov/pubmed/28614219
http://dx.doi.org/10.1097/MD.0000000000006884

Ejemplares similares